Clinical Report: Acute-Phase Clinical Phenotyping in CVST Outcomes

Overview

This study establishes a clinical phenotyping framework for predicting long-term cognitive and functional outcomes in patients with cerebral venous sinus thrombosis (CVST). The findings indicate that specific phenotypes, particularly Diffuse Brain Injury, are associated with significantly worse outcomes, including cognitive impairment and reduced return to work.

Background

Cerebral venous sinus thrombosis (CVST) can lead to severe long-term cognitive and functional impairments, yet existing prognostic tools primarily focus on survival. Understanding the acute-phase clinical phenotypes can enhance risk stratification and inform targeted rehabilitation strategies. This study addresses the gap in predicting long-term outcomes beyond survival rates.

Data Highlights

Key Findings

• The study involved 110 patients with CVST, categorized into three phenotypes: Benign Intracranial Hypertension, Focal Brain Injury, and Diffuse Brain Injury.
• Cognitive impairment rates were significantly higher in the Diffuse Brain Injury group (90.3%) compared to the Benign group (27.0%).
• Return to work was markedly lower in the Diffuse Brain Injury phenotype (32.3%) versus the Benign phenotype (89.2%).
• Both Focal and Diffuse Brain Injury phenotypes were identified as independent predictors of cognitive impairment.
• The Diffuse Brain Injury phenotype was also linked to a higher incidence of depressive symptoms and significantly reduced odds of returning to work.

Clinical Implications

Clinicians should utilize the acute-phase phenotyping framework to better predict long-term outcomes in CVST patients. Early identification of patients with the Diffuse Brain Injury phenotype may warrant more intensive and multidisciplinary interventions to improve prognosis.

Conclusion

The study presents a validated phenotyping approach that effectively stratifies CVST patients by their risk of long-term cognitive and functional impairments, emphasizing the need for tailored management strategies.

References

1. American Heart Association, Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement, 2024
2. Cognitive impairment after cerebral venous thrombosis: A systematic review and meta-analysis, 2025
3. Cerebral Venous Sinus Thrombosis in Immunocompetent Individuals with Cryptococcal Meningitis, The Journal of Infectious Diseases, 2024
4. Brain — Combined Influence of Cortical Cerebral Microinfarcts and Brain Atrophy on Cognitive Deterioration
5. European Radiology — Baseline CT Imaging of Cortical Atrophy as a Predictor of Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy
6. Management of Anticoagulation in Patients with Concurrent Traumatic Intracranial Hematomas and Cerebral Venous Sinus Thrombosis: A Cohort Observational Study
7. Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association
8. Cognitive impairment after cerebral venous thrombosis: A systematic review and meta-analysis - Luisa Medeiros Visentini, Gustavo Nascimento de Medeiros, Aluisio D’lucas Alves e Gomes, Wellisson Rodrigues Silva, Fernanda Alcântara Nascimento Aguiar, Julie de Lima Loiola, Giovanna Nina Ueda, Gabriel Marinheiro, Gabriel Barroso Cunha, Joao Brainer Clares de Andrade, Diana Aguiar de Sousa, Thales Pardini Fagundes, 2025
9. Endovascular thrombectomy for severe cerebral venous thrombosis: A comprehensive meta-analysis assessing safety and efficacy - Sherief Ghozy, Atakan Orscelik, Hatem Tolba, Mariam Abdelghaffar, Hassan Kobeissi, Hazem S. Ghaith, Alzhraa S. Abbas, Ramanathan Kadirvel, Waleed Brinjikji, David F. Kallmes, 2024